Addressing points raised by USFDA: Vista Pharma Industry-The Economic Times — July 13, 2017 comments off The Hyderabad-based company has been issued a warning letter by USFDA over significant violations of good manufacturing norms at its Nalgonda plant.
The Hyderabad-based company has been issued a warning letter by USFDA over significant violations of good manufacturing norms at its Nalgonda plant.